Norwegian Institute of Public Health
Oslo, 222, Norway
NCT Number: NCT07355569
This study has been designed as a randomized controlled trial including women invited to a national screening program for breast cancer in Norway, BreastScreen Norway in 2025. The program invites women aged 50-69 to biennial screening mammography. The study includes two substudies with the intervention of sending an SMS notification three days prior to the screening appointment in the first substudy and two days prior to the screening appointment in second study. The comparison is made between the study groups, where women are sent an SMS notification two or three days prior to their scheduled screening appointment and the control groups where women will not be sent an SMS notification about a scheduled screening appointment.
Looking for future studies?
Notify Me50 year–71 year
Female
Interventional
Not applicable
Oslo, 222, Norway
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Available in the NCCR and sent an SMS notification three or two days prior to a scheduled screening appointment
Time frame: Three months (180 days) after scheduled date for a screening examination following a routine invitation or three months (180 days) after a reminder was posted.
Attendance after a routine or reminder invitation, with and without an SMS notification
Norwegian Institute of Public Health
Other Gov
Sending SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway - the Effect on Attendance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02442089
Attendance
Santiago, Chile
View Trial DetailsNCT06939699
Breast Cancer Screening, Cervical Cancer Screening
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06640426
Annual Wellness Visit, Breast Cancer Screening
St Louis, Missouri, United States
View Trial DetailsNCT07472036
Behavior, Breast Cancer Screening
Antwerp, Belgium
View Trial Details